Difference between revisions of "Serpentis Inquest"
From EVE University Wiki
(Created page with "=Description= Serpentis Inquest is a offspring of the Serpentis Corporation that is also a research company, but instead of focusing on neural boosters Inquest is research...") |
(Still exists in game, no valid reason on deletion note. Removed deletion macro.) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | The '''Serpentis Inquest''' is a offspring of the [[Serpentis Corporation]] that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods. | |
| − | Serpentis Inquest is a offspring of the [[Serpentis Corporation]] that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods. | ||
| − | Ticker: SPI | + | ==Attributes== |
| + | *Ticker: SPI | ||
| + | *Headquarters: Serpentis Prime VI - Moon 1 - Serpentis Inquest Biotech Research Center | ||
| + | *Offices: 1 in 1 systems | ||
| + | *Shares: 332427989 | ||
| + | *Share price: 81 | ||
| + | *Activity: Biotech | ||
| + | *Partner: Eifyr and Co. | ||
| + | *Competitor: Zero-G Research Firm | ||
| − | + | ==CEO== | |
| − | + | Otuwiri Huohalen | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | = | + | ==Divisions== |
| − | + | ===Administration=== | |
| + | *CFO: Achi Astenaisen | ||
| − | = | + | ===Intelligence=== |
| − | == | + | *Chief Operative: Onlar Skadidsar |
| − | * | ||
| − | |||
| − | == | + | ===Production=== |
| − | * | + | *Production Manager: Engardin Trahad |
| − | |||
| − | == | + | ===Personnel=== |
| − | * | + | *Chief of Staff: Ersi Argrik |
| − | |||
| − | + | [[Category:Corporations]] | |
| − | |||
| − | |||
Latest revision as of 21:11, 30 August 2019
The Serpentis Inquest is a offspring of the Serpentis Corporation that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods.
Attributes
- Ticker: SPI
- Headquarters: Serpentis Prime VI - Moon 1 - Serpentis Inquest Biotech Research Center
- Offices: 1 in 1 systems
- Shares: 332427989
- Share price: 81
- Activity: Biotech
- Partner: Eifyr and Co.
- Competitor: Zero-G Research Firm
CEO
Otuwiri Huohalen
Divisions
Administration
- CFO: Achi Astenaisen
Intelligence
- Chief Operative: Onlar Skadidsar
Production
- Production Manager: Engardin Trahad
Personnel
- Chief of Staff: Ersi Argrik
